Monoclonal antibody may lead to long-term viral load reduction
Viral suppression maintained with alternate-day dosing of efavirenz/tenofovir/emtricitabine
EACS Standard of Care meeting report – Tackling HIV and co-infections in Europe: towards common standards
Opioid overdose deaths are rising among people with HIV in the United States
Non-adherence to HIV treatment for cost-saving reasons reported by 8% in American study
The impact of older antiretrovirals on fat redistribution and cardiovascular risk factors may be irreversible
Dolutegravir-based second-line ART achieves excellent virological outcomes even in the presence of resistance to recycled NRTIs
Co-administration of dolutegravir-based treatment and short course of rifapentine/isoniazid (3HP) well tolerated in people living with HIV
EACS takes steps towards a common, auditable European standard of care